Amending the Foreign Intelligence Surveillance Act
The Senate Intelligence Committee proposal to amend the Foreign Intelligence Surveillance Act (FISA), which is under consideration on the Senate floor today, “does not contain adequate protections to guard against the kind of Executive abuse that occurred with the [Terrorist Surveillance Program] and related programs,” according to a new Senate Judiciary Committee report.
“Congress is prepared to grant the Administration the authority it needs to surveil targets overseas. But the unilateral decision by the Executive in the years following 9/11 to surveil Americans’ communications contrary to FISA illustrates the need for Congress to provide clear statutory protections for surveillance that impacts Americans’ privacy rights.”
“Additional protections are of critical importance,” the Senate Judiciary Committee report said. “The rules governing electronic surveillance affect every American and remain the only buffer between the freedom of Americans to make private communications and the ability of the Government to listen in on those communications.”
“In the Committee’s view, the improvements contained in the Senate Intelligence bill do not go far enough in ensuring that Americans’ privacy rights are safeguarded. Additional protections can be added without interfering with the flexibility the Government needs to conduct overseas surveillance.”
See “Foreign Intelligence Surveillance Act of 1978 Amendments Act of 2007,” Senate Judiciary Committee, January 22.
Using the NIST as an example, the Radiation Physics Building (still without the funding to complete its renovation) is crucial to national security and the medical community. If it were to go down (or away), every medical device in the United States that uses radiation would be decertified within 6 months, creating a significant single point of failure that cannot be quickly mitigated.
The federal government can support more proactive, efficient, and cost-effective resiliency planning by certifying predictive models to validate and publicly indicate their quality.
We need a new agency that specializes in uncovering funding opportunities that were overlooked elsewhere. Judging from the history of scientific breakthroughs, the benefits could be quite substantial.
The cost of inaction is not merely economic; it is measured in preventable illness, deaths and diminished livelihoods.